Evaluation of the Khorana, PROTECHT, and 5‐SNP scores for prediction of venous thromboembolism in patients with cancer
Noori A.M. Guman, Roos J. van Geffen, Frits I. Mulder, Thijs F. van Haaps, Vahram Hovsepjan, Mariëtte Labots, Geert A. Cirkel, Filip De Vos, Albert J. ten Tije, Laurens V. Beerepoot, Vivianne C. G. Tjan‐Heijnen, Hanneke W.M. van Laarhoven, Paul Hamberg, Annelie Vulink, Maartje Los, Aeilko H. Zwinderman, Bart Ferwerda, Martijn P. Lolkema, Neeltje Steeghs, Harry R. Büller, Pieter W. Kamphuisen, Nick van Es
Topics & Concepts
MedicineInternal medicineConfidence intervalHazard ratioVenous thromboembolismGastroenterologyThrombosisVenous Thromboembolism Diagnosis and ManagementInflammatory Biomarkers in Disease PrognosisCardiac tumors and thrombi